Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 08 Feb 2021 |
2 | Reply to Exam Report (MIS-R) | 06 Mar 2021 |
3 | Journal Copy | 07 Feb 2023 |
4 | TM-O(NOTICE OF OPPOSITION) | 24 Apr 2023 |
5 | Annexure -1 under rule 46 | 04 Jun 2024 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 04 Jun 2024 |
6 | Annexure -1 under rule 46 | 04 Jun 2024 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 04 Jun 2024 |
1 | EXAMINATION REPORT | 11124099 | 17 Feb 2021 | |
2 | Hearing Notice (Show Cause) | 12966257 | 07 Feb 2022 | |
3 | Hearing Notice (Show Cause) | 14086247 | 14 Sep 2022 | |
4 | Tribunal Accepted Notice for : 4853962 | 14505961 | 5801143 | 19 Dec 2022 |
5 | Opposition Notice | 16514223 | 6339949 | 09 Nov 2023 |
6 | Opposition Counter Statement | 17342610 | 6533091 | 08 Feb 2024 |
Trademark was applied on 08 February 2021 with IP India.
Proprietor of Foctum is NEPHUROCARE PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Foctum is Opposed.
Application number alloted to the trademark is 4853962.
Jayshruti Hariprasadbhai Acharya is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE